E, Legros, D, Torreele, E. Developing a
needs-based and rational approach to identify neglected diseases and select
R&D projects that could maximally impact treatment options. Drugs
for Neglected Diseases Working group, MSF, 2001: A thorough analysis of
neglected diseases and the problems in priority setting. Includes analyses of
different ways of presenting available data and proposes a “policy strategy”
for priority setting for neglected diseases
Trouiller P, Olliaro P, Torreele E,
Orbinski J, Laing R, Ford N. Drug
development for neglected diseases: a deficient market and a public-health
policy failure. Lancet. 2002 Jun 22;359(9324):2188-94. An in-depth analysis of the
current pharmaceutical discovery process and the failure of the system to
address the needs of neglected diseases.
Reprinted with permission from Elsevier. (Lancet 2002;359(9324):2188-2194). The Lancet Homepage is at http://www.thelancet.com
Legros D, Ollivier G, Gastellu-Etchegorry M,
Paquet C, Burri C, Jannin J, Buscher P. Treatment of human African
trypanosomiasis--present situation and needs for research and development.
Lancet Infect Dis. 2002 Jul;2(7):437-40.
A needs-based analysis of the problems identified in treating HAT.
Reprinted with permission from Elsevier. (Lancet Infect Dis 2002;2(7):437-440).
Guerin PJ, Olliaro P, Sundar S, Boelaert M,
Croft SL, Desjeux P, Wasunna MK, Bryceson AD. (2002a) Visceral
leishmaniasis: current status of control, diagnosis, and treatment, and a
proposed research and development agenda. Lancet Infect Dis. 2002 Aug;2(8):494-501. An analysis, carried out
in a similar way to annex 4, of the needs-based priority agenda for a response
Reprinted with permission from Elsevier. (Lancet Infect Dis 2002;2(8):494-501).
Ahoua L. & Torreele E.
Prise en Charge de l’ulcère de Buruli: medicament disponibles et perspectives.
working paper, 2004. An
analysis of the current treatment options for Buruli Ulcer including available
treatments and future possibilities.
6 [pdf 132KB]
ACP-EU Joint Parliamentary Assembly
on poverty-related diseases and reproductive health in ACP States,
ACP-EU 3640/04/fin. A clear commitment
on the part of the EU to addressing health needs in developing countries, and
affirms the EU responsibility to act.